Using cannabis to manage symptoms of pregnancy and breastfeeding
According to new research, more people are using cannabis to manage symptoms of pregnancy and breastfeeding, such as nausea, vomiting, mental health problems and...
Epileptic seizure frequency fell by 86% in kids treated with medicinal cannabis
A new study found that epileptic seizure frequency fell by an average of 86% amongst 10 children treated with whole-plant medicinal cannabis.
Whole plant medicinal...
New report calls for UK to capitalise on potential £1.2bn medical cannabis industry
A new report by drug policy reform advocacy group Volteface has revealed the UK is missing out on a potential £1.2bn medical cannabis industry...
Fluence announce partnership with White Lion Holdings to revolutionise South African cannabis industry
Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, has announced a partnership with...
The current landscape of medical cannabis in the United States
Dr Leigh Vinocur, Chief Medical Officer of cannabis consulting company Ananda Medical Practice and member of the Society of Cannabis Clinicians, discusses the state...
Leafcann edible essential oils range hits the market
Pioneers of the plant-based medicine industry Leafcann has announced that its new edible essential oils range is now available on the pharmaceutical market.
The product...
Cannabis cultivation, tissue culture, and quality control
Cannadabis leverages its years of industry experience to craft proprietary and highly sought-after cannabis cultivation systems.
Headquartered in Humboldt, Saskatchewan, Canada, Cannadabis Medical Inc is...
Chronic spontaneous urticaria: could the answer be in CBD?
Dr Sari Prutchi Sagiv, CSO of Stero Biotechs, explains why CBD could be a potential treatment for chronic spontaneous urticaria.
Urticaria can be caused by...
Cannabis use in Australia rose significantly during first COVID-19 lockdown
Cannabis use in Australia spiked during the first COVID-19 lockdown period whilst methamphetamine use fell dramatically, a study has found.
Research led by the University...
Cannabis-based mouth spray to be trialled as treatment for brain tumours
A major UK trial will analyse the efficacy of an oral cannabis-based spray to treat the most aggressive form of brain tumours.
In a phase...
Get ready for the International Cannabis Business Conference
The International Cannabis Business Conference will return to Berlin, Germany, on 25-27 August 2021.
Providing a whole host of industry networking opportunities, the conference will...
Medical cannabis and its use for people with fibromyalgia
Dr Mark Ware, Chief Medical Officer at Canopy Growth Corporation, discusses medical cannabis as a treatment for fibromyalgia.
Fibromyalgia, also referred to as fibromyalgia syndrome...
Revolutionising medical cannabis cultivation across Europe
Timo Bongartz, General Manager at Fluence EMEA, explains how the company is helping to transform medical cannabis cultivation across Europe with its innovative LED...
Symtomax: innovation in European cannabis
Portugal-based cannabis producer Symtomax deploys industry experience and genetic expertise to deliver high-quality, market-leading products.
Symtomax has been granted approval by INFARMED, the Portuguese regulatory...
Fibromyalgia patients swapping opioids for CBD to manage pain
New research has shown that patients living with the chronic pain condition of fibromyalgia are swapping opioids for CBD in a bid to manage...
New data from UK Medical Cannabis Registry presented at symposium
Sapphire Medical Clinics has presented new data from the UK Medical Cannabis Registry at the 31st Annual International Cannabinoid Research Society Symposium on the...
Association for the Cannabinoid Industry to expand EU Offering
The Association for the Cannabinoid Industry (ACI) has announced the opening of a new Brussels office as they expand their membership offering into the...
Immune system dysfunction and cannabis use linked to psychosis
A combination of inflammatory cytokines in the blood and regular cannabis use, or use at a young age, can increase the chances of developing...
Researching cannabis-based drugs for COVID and glyblactoma multiforma
Global thought leaders in cannabis came together for the GCI Summit from 8 to 10 June which explored policy, research, investment and more across...
Campaigner requests meeting with PM to discuss NHS medical cannabis
Medical cannabis campaigner Hannah Deacon has delivered a letter to UK Prime Minister, Boris Johnson, requesting a meeting to discuss medical cannabis access on...
